PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phentermine Hydrochloride And Topiramate, and what generic alternatives are available?
Phentermine Hydrochloride And Topiramate is a drug marketed by Actavis Labs Fl Inc and is included in one NDA.
The generic ingredient in PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE is phentermine hydrochloride; topiramate. There are seventeen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the phentermine hydrochloride; topiramate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phentermine Hydrochloride And Topiramate
A generic version of PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE was approved as phentermine hydrochloride; topiramate by ACTAVIS LABS FL INC on June 25th, 2024.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE?
- What are the global sales for PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE?
- What is Average Wholesale Price for PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE?
Summary for PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 25 |
| DailyMed Link: | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE at DailyMed |
Recent Clinical Trials for PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Minnesota | Early Phase 1 |
| University of Minnesota | Phase 3 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
See all PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE clinical trials
US Patents and Regulatory Information for PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 204982-001 | Jun 25, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Actavis Labs Fl Inc | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 204982-004 | Jun 25, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Actavis Labs Fl Inc | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 204982-002 | Jun 25, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Actavis Labs Fl Inc | PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 204982-003 | Jun 25, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
